Association of endocrine disruptors and obesity: Perspectives from epidemiological studies

International Journal of Andrology

Volumn 33, Issue 2, 2010, Pages 324-332

  Hatch, E E ^a   Nelson, J W ^a   Stahlhut, R W ^b   Webster, T F ^a  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Endocrine disrupting chemicals; Epidemiology; NHANES; Obesity; Phthalates

Indexed keywords

ENDOCRINE DISRUPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PESTICIDE; PHTHALIC ACID; SEX HORMONE; PROGESTERONE RECEPTOR;

ADIPOGENESIS; AGE DISTRIBUTION; BODY MASS; CONFERENCE PAPER; DISEASE ASSOCIATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; OBESITY; PRENATAL EXPOSURE; PRIORITY JOURNAL; SEX DIFFERENCE; THYROID FUNCTION; WAIST CIRCUMFERENCE; BODY COMPOSITION; ESTROGEN ACTIVITY; MAMMARY GLAND; POSTMENOPAUSE; UTERUS WEIGHT;

EID: 77949600626     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2009.01035.x     Document Type: Conference Paper

References (61)

1. Ahima RS Flier JS. (2000) Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11, 327 332.
2. Baillie-Hamilton PF. (2002) Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med 8, 185 192.
3. Barber TM, McCarthy MI, Wass JA Franks S. (2006) Obesity and polycystic ovary syndrome. Clin Endocrinol 65, 137 145.
4. Ben-Jonathan N, Hugo ER Brandebourg TD. (2009) Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome. Mol Cell Endocrinol 304, 49 54.
5. Berghofer AT, Pischon T, Rinehold T, Apovian CM, Sharma AM Willich SN. (2008) Obesity prevalence from a European perspective: a systematic review. BMC Public Health 8, 200.
6. Bjorntorp P. (1996) The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 20, 291 302.
7. Blanck HM, Marcus M, Rubin C, Tolbert PE, Hertzberg VS, Hendersen AK Zhang RH. (2002) Growth in girls exposed in utero and postnatally to polybrominated biphenyls and polychlorinated biphenyls. Epidemiology 13, 205 210.
8. Casals-Casas C, Feige JN Desvergne B. (2008) Interference of pollutants with PPARs: endocrine disruption meets metabolism. Int J Obes (Lond) 32 (Suppl 6 S53 S61.
9. Centers for Disease Control and Prevention (CDC) (2005) Third National Report on Human Exposure to Environmental Chemicals. CDC, Atlanta.
10. Centers for Disease Control and Prevention (CDC) (2008) Health United States. CDC, Atlanta.
11. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT Gore AC. (2009) Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 30, 293 342.
12. Evans RM, Barish GD Wang YX. (2004) PPARs and the complex journey to obesity. Nat Med 10, 355 361.
13. Fei C, McLaughlin JK, Tarone RE Olsen J. (2007) Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 115, 1677 1682.
14. Gapstur SM, Gann PH, Kopp P, Colangelo L, Longcope C Liu K. (2002) Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomarkers Prev 11, 1041 1047.
15. Gerchman F, Tong J, Utzschneider KM, Zraika S, Udayasankar J, McNeely MJ, et al. (2009) Body mass index is associated with increased creatinine clearance by a mechanism independent of body fat distribution. J Clin Endocrinol Metab 94, 3781 3788.
16. Gladen BC, Ragan NB Rogan WJ. (2000) Pubertal growth and development and prenatal and lactational exposure to polychlorinated biphenyls and dichlorodiphenyl dichloroethene. J Pediatr 136, 490 496.
17. Gladen BC, Klebanoff MA, Hediger ML, Katz SH, Barr DB, Davis MD Longnecker MP. (2004) Prenatal DDT exposure in relation to anthropometric and pubertal measures in adolescent males. Environ Health Perspect 112, 1761 1767.
18. Gluckman PD, Hanson MA, Cooper C Thornburg K. (2008) Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 359, 61 73.
19. Goodman H. (2009) Basic Medical Endocrinology. Academic Press, New York, NY.
20. Grun F Blumberg B. (2006) Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147 (6 Suppl S50 S55.
21. Grun F Blumberg B. (2009) Endocrine disrupters as obesogens. Mol Cell Endocrinol 304, 19 29.
22. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL Anis AH. (2009) The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 9, 88.
23. Hamilton MT, Hamilton DG Zderic TW. (2007) Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 56, 2655 2667.
24. Hatch EE, Nelson JW, Qureshi MM, Weinberg J, Moore LL, Singer M Webster TF. (2008) Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002. Environ Health 7, 27.
25. Hauser R, Meeker JD, Park S, Silva MJ Calafat AM. (2004) Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ Health Perspect 112, 1734 1740.
26. Heindel JJ. (2003) Endocrine disruptors and the obesity epidemic. Toxicol Sci 76, 247 249.
27. Heindel JJ vom Saal FS. (2009) Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity. Mol Cell Endocrinol 304, 90 96.
28. Hines EP, White SS, Stanko JP, Gibbs-Flournoy EA, Lau C Fenton SE. (2009) Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life. Mol Cell Endocrinol 304, 97 105.
29. Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG vom Saal FS. (1999) Exposure to bisphenol A advances puberty. Nature 401, 763 764.
30. Huang JS, Lee TA Lu MC. (2007) Prenatal programming of childhood overweight and obesity. Matern Child Health J 11, 461 473.
31. Hurst CH Waxman DJ. (2003) Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. Toxicol Sci 74, 297 308.
32. Karmaus W, Osuch JR, Eneli I, Mudd LM, Zhang J, Mikucki D, Haan P Davis S. (2009) Maternal levels of dichlorodiphenyl-dichloroethylene (DDE) may increase weight and body mass index in adult female offspring. Occup Environ Med 66, 143 149.
33. Keith SW, Redden DT, Katzmarzyk PT, Boggiano MM, Hanlon EC, Benca RM, et al. (2006) Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes (Lond) 30, 1585 1594.
34. Knudsen N, Laurberg P, Rasmussen LB, Bülow I, Perrild H, Ovesen L Jørgensen T. (2005) Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 90, 4019 4024.
35. Kortenkamp A. (2007) Ten years of mixing cocktails - a review of combination effects of endocrine disrupting chemicals. Environ Health Perspect 115 (Suppl 1 98 105.
36. Leibel RL, Rosenbaum M Hirsch J. (1995) Changes in energy expenditure resulting from altered body weight. N Engl J Med 332, 621 628.
37. Longnecker MP. (2006) Pharmacokinetic variability and the miracle of modern analytical chemistry. Epidemiology 17, 350 351.
38. Lovejoy JC Sainsbury A. (2009) Sex differences in obesity and the regulation of energy homeostasis. Obes Rev 10, 154 167.
39. Main KM, Mortensen GK, Kaleva MM, Boisen KA, Damgaard IN, Chellakooty M, et al. (2006) Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ Health Perspect 114, 270 276.
40. Martorell R, Khan LK, Hughes ML Grummer-Strawn LM. (2000) Obesity in women from developing countries. Eur J Clin Nutr 54, 247 252.
41. Newbold RR, Padilla-Banks E, Snyder RJ Jefferson WN. (2005) Developmental exposure to estrogenic compounds and obesity. Birth Defects Res A Clin Mol Teratol 73, 478 480.
42. Newbold RR, Padilla-Banks E Jefferson WN. (2009) Environmental estrogens and obesity. Mol Cell Endocrinol 304, 84 89.
43. Oken E Gillman MW. (2003) Fetal origins of obesity. Obes Res 11, 496 506.
44. Olsen GW, Gilliland FD, Burlew MM, Burris JM, Mandel JS Mandel JH. (1998) An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J Occup Environ Med 40, 614 622.
45. Pan G, Hanaoka T, Yoshimura M, Zhang S, Wang P, Tsukino H, Inoue K, Nakazawa H, Tsugane S Takahashi K. (2006) Decreased serum free testosterone in workers exposed to high levels of di-n-butyl phthalate (DBP) and di-2-ethylhexyl phthalate (DEHP): a cross-sectional study in China. Environ Health Perspect 114, 1643 1648.
46. Pasquali R. (2006) Obesity and androgens: facts and perspectives. Fertil Steril 85, 1319 1340.
47. Patandin S, Koopman-Esseboom C, de Ridder MA, Weisglas-Kuperus N Sauer PJ. (1998) Effects of environmental exposure to polychlorinated biphenyls and dioxins on birth size and growth in Dutch children. Pediatr Res 44, 538 545.
48. Ribas-Fitó N, Gladen BC, Brock JW, Klebanoff MA Longnecker MP. (2006) Prenatal exposure to 1,1-dichloro-2,2-bis (p-chlorophenyl)ethylene (p,p'-DDE) in relation to child growth. Int J Epidemiol 35, 853 888.
49. Rubin BS Soto AM. (2009) Bisphenol A: perinatal exposure and body weight. Mol Cell Endocrinol 304, 55 62.
50. Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, Caudill SP, Brock JW, Needham LL Calafat AM. (2004) Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect 112, 331 338.
51. Smink A, Ribas-Fito N, Garcia R, Torrent M, Mendez MA, Grimalt JO Sunyer J. (2008) Exposure to hexachlorobenzene during pregnancy increases the risk of overweight in children aged 6 years. Acta Paediatr 97, 1465 1469.
52. Stahlhut RW, van Wijngaarden E, Dye TD, Cook S Swan SH. (2007) Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ Health Perspect 115, 876 882.
53. Swan SH. (2008) Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ Res 108, 177 184.
54. Trasande L, Cronk C, Durkin M, Weiss M, Schoeller DA, Gall EA, Hewitt JB, Carrel AL, Landrigan PJ Gillman MW. (2009) Environment and obesity in the National Children's Study. Environ Health Perspect 117, 159 166.
55. Verhulst SL, Nelen V, Hond ED, Koppen G, Beunckens C, Vael C, Schoeters G Desager K. (2009) Intrauterine exposure to environmental pollutants and body mass index during the first 3 years of life. Environ Health Perspect 117, 122 126.
56. Webster TF. (2006) Pharmacokinetics of POPs: simple models with different implications for halflives and steady state levels. Organohalogen Compounds 68, 344 347.
57. Wigle DT, Arbuckle TE, Turner MC, Bérubé A, Yang Q, Liu S Krewski D. (2008) Epidemiologic evidence of relationships between reproductive and child health outcomes and environmental chemical contaminants. J Toxicol Environ Health B Crit Rev 11, 373 517.
58. Wohlfahrt-Veje C, Andersen HR, Jensen TK, Grandjean P, Skakkebaek N Main KM 2009) Long-term effects of prenatal pesticide exposure on several endocrine functions in children. 5th Copenhagen Workshop on Endocrine Disruptors, Copenhagen.
59. Wolff MS, Anderson HA, Britton JA Rothman N. (2007a) Pharmacokinetic variability and modern epidemiology the example of dichlorodiphenyltrichloroethane, body mass index, and birth cohort. Cancer Epidemiol Biomarkers Prev 16, 1925 1930.
60. Wolff MS, Teitelbaum SL, Windham G, Pinney SM, Britton JA, Chelimo C, et al. (2007b) Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls. Environ Health Perspect 115, 116 121.
61. Zoeller RT. (2007) Environmental chemicals impacting the thyroid: targets and consequences. Thyroid 17, 811 817.